New Studies Show Triple-Therapy with Crixivan (R) Drops HIV to Undetectable Levels in Patients in All Stages of HIV Disease [Conference on Retroviruses and Opportunistic Infections (4th: 1997: Washingoton, DC)]
Viewer
About this Item
- Title
- New Studies Show Triple-Therapy with Crixivan (R) Drops HIV to Undetectable Levels in Patients in All Stages of HIV Disease [Conference on Retroviruses and Opportunistic Infections (4th: 1997: Washingoton, DC)]
- Author
- Merck & Co.
- Canvas
- Page 5
- Publication
- Merck
- 1997-01-26
- Item type:
- press releases
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0120.055
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0120.055/6
Rights and Permissions
Where applicable, subject to copyright. Other restrictions on distribution may apply. Please go to http://www.umdl.umich.edu/ for more information.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0120.055
Cite this Item
- Full citation
-
"New Studies Show Triple-Therapy with Crixivan (R) Drops HIV to Undetectable Levels in Patients in All Stages of HIV Disease [Conference on Retroviruses and Opportunistic Infections (4th: 1997: Washingoton, DC)]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0120.055. University of Michigan Library Digital Collections. Accessed May 9, 2024.